A De Novo Dominant Negative Mutation in DNM1L Causes Sudden Onset Status Epilepticus with Subsequent Epileptic Encephalopathy

Abstract

Mitochondrial dynamics such as fission and fusion play a vital role in normal brain development and neuronal activity. DNM1L encodes a dynamin-related protein 1 (Drp1), which is a GTPase essential for proper mitochondrial fission. The clinical phenotype of DNM1L mutations depends on the degree of mitochondrial fission deficiency, ranging from severe encephalopathy and death shortly after birth to initially normal development and then sudden onset of refractory status epilepticus with very poor neurologic outcome. We describe a case of a previously healthy 3-year-old boy with a mild delay in speech development until the acute onset of a refractory status epilepticus with subsequent epileptic encephalopathy and very poor neurologic outcome. The de novo missense mutation in DNM1L (c.1207C > T, p.R403C), which we identified in this case, seems to determine a unique clinical course, strikingly similar to four previously described patients in literature with the identical de novo heterozygous missense mutation in DNM1L.

Keywords

epileptic encephalopathy - DNM1L - Drp1 - mitochondrial fission - status epilepticus - childhood epilepsy

• References

• 1 Itoh K, Nakamura K, Iijima M, Sesaki H. Mitochondrial dynamics in neurodegeneration. Trends Cell Biol 2013; 23 (02) 64-71
• 2 Smirnova E, Griparic L, Shurland D-L, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001; 12 (08) 2245-2256
• 3 Smirnova E, Shurland D-L, Ryazantsev SN, van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 1998; 143 (02) 351-358
• 4 Wakabayashi J, Zhang Z, Wakabayashi N. , et al. The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J Cell Biol 2009; 186 (06) 805-816
• 5 Gerber S, Charif M, Chevrollier A. , et al. Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission. Brain 2017; 140 (10) 2586-2596
• 6 Barbet F, Hakiki S, Orssaud C. , et al. A third locus for dominant optic atrophy on chromosome 22q. J Med Genet 2005; 42 (01) e1
• 7 Nasca A, Legati A, Baruffini E. , et al. Biallelic mutations in DNM1L are associated with a slowly progressive infantile encephalopathy. Hum Mutat 2016; 37 (09) 898-903
• 8 Yoon G, Malam Z, Paton T. , et al; Finding of Rare Disease Genes (FORGE) in Canada Consortium Steering Committee. Lethal disorder of mitochondrial fission caused by mutations in DNM1L. J Pediatr 2016; 171: 313-6.e1 , 2
• 9 Chao Y-H, Robak LA, Xia F. , et al. Missense variants in the middle domain of DNM1L in cases of infantile encephalopathy alter peroxisomes and mitochondria when assayed in Drosophila. Hum Mol Genet 2016; 25 (09) 1846-1856
• 10 Sheffer R, Douiev L, Edvardson S. , et al. Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1L mutation causing impaired mitochondrial fission and function. Am J Med Genet A 2016; 170 (06) 1603-1607
• 11 Vanstone JR, Smith AM, McBride S. , et al; Care4Rare Consortium. DNM1L-related mitochondrial fission defect presenting as refractory epilepsy. Eur J Hum Genet 2016; 24 (07) 1084-1088
• 12 Chang C-R, Manlandro CM, Arnoult D. , et al. A lethal de novo mutation in the middle domain of the dynamin-related GTPase Drp1 impairs higher order assembly and mitochondrial division. J Biol Chem 2010; 285 (42) 32494-32503
• 13 Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007; 356 (17) 1736-1741
• 14 Fahrner JA, Liu R, Perry MS, Klein J, Chan DC. A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy. Am J Med Genet A 2016; 170 (08) 2002-2011
• 15 Ladds E, Whitney A, Dombi E. , et al. De novo DNM1L mutation associated with mitochondrial epilepsy syndrome with fever sensitivity. Neurol Genet 2018; 4 (04) e258